Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Zegfrovy
Generic name : Sunvozertinib
Manufactured By : Dizal Pharmaceuticals Co Ltd
Indications : NSCLC
Medicine Description : Sunvozertinib (brand name WuShiKe) is an oral EGFR tyrosine kinase inhibitor (TKI) designed to selectively target EGFR exon 20 insertion mutations in non-small cell lung cancer (NSCLC). It has shown strong antitumor activity with durable responses in clinical trials. Approved in China in 2023 for advanced NSCLC, common side effects include diarrhea, rash, decreased appetite, and elevated liver enzymes.